Sie suchten nach: current smoking (Englisch - Maltesisch)

smoking
tipjip

stop smoking
tpejjipx iżjed

no smoking.
tpejjipx.

smoking tobacco
tabakk tat-tipjip

6 by smoking (
6 s ruħ imutu kull sena bit-tipjip (

tobacco for smoking
tabakk għat-tipjip

smoking tobacco product
prodott tat-tabakk idaħħan

other smoking tobacco.
tabakk ieħor għat-tipjip.

other smoking tobaccos:
tabakk ieħor tat-tipjip:

smoking tobacco 400 grams
jew tabakk għal tipjip 400 gramm

for other smoking tobacco:
għal tabakk ieħor għat-tipjip:

special prize: smoking cessation
premju speċjali: il-waqfien mit-tipjip

smoking causes fatal lung cancer.
it-tipjip jikkawża kanċer fatali tal-pulmun.

current smokers should be advised to stop smoking due to a risk of a lower response.
persuni li bħalissa jpejpu għandhom jingħataw parir biex jieqfu jpejpu minħabba riskju ta’ rispons iktar baxx.

enclosed, separately ventilated smoking rooms
kmamar magħluqin għat-tipjip, ivventilati separatament

smoking tobacco (excluding tobacco duty)
tabakk tat-tipjip (eskluż dazju tat-tabakk)

special prize topic: smoking cessation.
suġġett bi premju speċjali: il-waqfien mit-tipjip.

patient factors, which correlated with erlotinib pharmacokinetics, were serum total bilirubin, aag and current smoking.
fatturi tal-pazjent, li jikkorrelaw mal-farmakokinetika ta’ erlotinib, kienu total tal-bilirubina fis-serum, aag u jekk il-pazjent hux qed ipejjep.

61% of current smokers have already tried to quit smoking, including 1 in 5 in the year prior to the survey
perċentwal ta’ 61% tal-persuni li jpejpu bħalissa diġà ppruvaw jieqfu jpejpu, inkluż persuna minn kull ħamsa fis-sena ta’ qabel l-istħarriġ

risk factors for pneumonia in patients with copd include current smoking, older age, low body mass index (bmi) and severe copd.
fatturi ta’ riskju għal pulmonite f’pazjenti b’copd jinkludu tipjip attwali, età ikbar, kurrenti, indiċi tal-massa tal-ġisem baxx (bmi, body mass index) u copd severa.